Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding

Yin Chuan Jin, Hahnbie Lee, Seung Woo Kim, Il Doo Kim, Hye Kyung Lee, Yunjin Lee, Pyung Lim Han, Ja Kyeong Lee

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Osteopontin (OPN) is a phosphorylated glycoprotein possessing an arginine-glycine-aspartate (RGD)-motif, which binds to several cell surface integrins and mediates a wide range of cellular processes. Inductions of OPN have been reported in the postischemic brain, and the neuroprotective effects of OPN have been demonstrated in animal models of stroke. In the present study, we showed a robust neuroprotective effect of RGD-containing icosamer OPN peptide (OPNpt20) in a rat model of focal cerebral ischemia (middle cerebral artery occlusion, MCAO). Intranasally administered OPNpt20 reduced mean infarct volume by 79.7 % compared to the treatment-naïve MCAO control animals and markedly ameliorated neurological deficits. In addition, OPNpt20 significantly suppressed the inductions of iNOS and of inflammatory markers in postischemic brains and in primary microglial cultures, demonstrating anti-inflammatory effects. Administration of a mutant peptide, in which RGD was replaced by arginine-alanine-alanine (RAA), failed to suppress infarct volumes in MCAO animals and co-administration of OPNpt20 with anti-αvβ3 integrin antibody failed to suppress iNOS induction in primary microglia culture, indicating that the RGD motif in OPNpt20 and endogenous αvβ3 integrin play critical roles. Furthermore, pull-down assay revealed a direct binding between OPNpt20 and αvβ3 integrin in primary microglia culture. Together, these results indicate that RGD-containing OPN icosamer has therapeutic potential in the postischemic brain and αvβ3 integrin-mediated anti-inflammatory effect might be an underlying mechanism.

Original languageEnglish
Pages (from-to)5652-5663
Number of pages12
JournalMolecular Neurobiology
Issue number8
StatePublished - 1 Oct 2016

Bibliographical note

Funding Information:
This work was financially supported by a Medical Research Center Grant 2014R1A5A2009392 (to J.-K.L.) funded by the National Research Foundation (NRF) of Korea.

Publisher Copyright:
© 2015, Springer Science+Business Media New York.


  • Icosamer
  • Inflammation
  • MCAO
  • Neuroprotection
  • Osteopontin
  • RGD


Dive into the research topics of 'Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via αvβ3 Integrin Binding'. Together they form a unique fingerprint.

Cite this